Modeling Targeted Inhibition of MEK and PI3 Kinase in Human Pancreatic Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-0030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Casein Kinase II Inhibition Induces Apoptosis in Pancreatic Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2007English

Response to MEK Inhibition With Trametinib and Tyrosine Kinase Inhibition With Imatinib in Multifocal Histiocytic Sarcoma

Haematologica
Hematology
2017English

Targeted Therapies for Pancreatic Cancer

Cancers
Cancer ResearchOncology
2018English

Endothelial Cell Rearrangements During Vascular Patterning Require PI3-kinase-mediated Inhibition of Actomyosin Contractility

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted by Epidermal Growth Factor Receptor Inhibition

Clinical Cancer Research
Cancer ResearchOncology
2014English

siRNA-targeted Inhibition of Growth Hormone Receptor in Human Colon Cancer SW480 Cells

World Journal of Gastroenterology
MedicineGastroenterology
2013English

Molecular Targeted Therapies for Pancreatic Cancer

American Journal of Surgery
MedicineSurgery
2008English

Targeted Therapies for Pancreatic Cancer and Hurdles Ahead

Anticancer Research
MedicineCancer ResearchOncology
2018English

The Human Kinome and Kinase Inhibition

Current Protocols in Pharmacology
MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy